These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26524606)

  • 1. Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2.
    Felts AS; Rodriguez AL; Smith KA; Engers JL; Morrison RD; Byers FW; Blobaum AL; Locuson CW; Chang S; Venable DF; Niswender CM; Daniels JS; Conn PJ; Lindsley CW; Emmitte KA
    J Med Chem; 2015 Nov; 58(22):9027-40. PubMed ID: 26524606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.
    Felts AS; Rodriguez AL; Morrison RD; Venable DF; Blobaum AL; Byers FW; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1894-900. PubMed ID: 26988308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative allosteric modulators of group II metabotropic glutamate receptors: A patent review (2015 - present).
    Qunies AM; Emmitte KA
    Expert Opin Ther Pat; 2021 Aug; 31(8):687-708. PubMed ID: 33719801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel metabotropic glutamate receptor 2/3 antagonists and their therapeutic applications: a patent review (2005 - present).
    Celanire S; Sebhat I; Wichmann J; Mayer S; Schann S; Gatti S
    Expert Opin Ther Pat; 2015 Jan; 25(1):69-90. PubMed ID: 25435285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
    Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis.
    Benneyworth MA; Xiang Z; Smith RL; Garcia EE; Conn PJ; Sanders-Bush E
    Mol Pharmacol; 2007 Aug; 72(2):477-84. PubMed ID: 17526600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2017 Mar; 115():115-127. PubMed ID: 28216000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
    Layton ME; Reif AJ; Hartingh TJ; Rodzinak K; Dudkin V; Wang C; Arrington K; Kelly MJ; Garbaccio RM; O'Brien JA; Magliaro BC; Uslaner JM; Huszar SL; Fillgrove KL; Tang C; Kuo Y; Jacobson MA
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1260-4. PubMed ID: 26810316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2.
    Lundström L; Bissantz C; Beck J; Dellenbach M; Woltering TJ; Wichmann J; Gatti S
    Neuropharmacology; 2016 Dec; 111():253-265. PubMed ID: 27590915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.
    Felts AS; Rodriguez AL; Morrison RD; Blobaum AL; Byers FW; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1679-1685. PubMed ID: 29705142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity.
    Galici R; Echemendia NG; Rodriguez AL; Conn PJ
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1181-7. PubMed ID: 16123306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators.
    Jimenez HN; Liu KG; Hong SP; Reitman MS; Uberti MA; Bacolod MD; Cajina M; Nattini M; Sabio M; Doller D
    Bioorg Med Chem Lett; 2012 May; 22(9):3235-9. PubMed ID: 22465637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based discovery and development of metabotropic glutamate receptor 5 negative allosteric modulators.
    Bennett KA; Christopher JA; Tehan BG
    Adv Pharmacol; 2020; 88():35-58. PubMed ID: 32416871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of systemically active metabotropic glutamate subtype-2 and -3 (mGlu2/3) receptor positive allosteric modulators (PAMs): pharmacological characterization and assessment in a rat model of cocaine dependence.
    Dhanya RP; Sheffler DJ; Dahl R; Davis M; Lee PS; Yang L; Nickols HH; Cho HP; Smith LH; D'Souza MS; Conn PJ; Der-Avakian A; Markou A; Cosford ND
    J Med Chem; 2014 May; 57(10):4154-72. PubMed ID: 24735492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacology of metabotropic glutamate receptor allosteric modulators: structural basis and therapeutic potential for CNS disorders.
    Gregory KJ; Noetzel MJ; Niswender CM
    Prog Mol Biol Transl Sci; 2013; 115():61-121. PubMed ID: 23415092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
    Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
    Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.
    Engers JL; Rodriguez AL; Konkol LC; Morrison RD; Thompson AD; Byers FW; Blobaum AL; Chang S; Venable DF; Loch MT; Niswender CM; Daniels JS; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
    J Med Chem; 2015 Sep; 58(18):7485-500. PubMed ID: 26335039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of 4-arylquinoline-2-carboxamides, highly potent and selective class of mGluR2 negative allosteric modulators: From HTS to activity in animal models.
    Shu Y; Diamond TL; Hershey JC; Huang S; Magliaro BC; O'Brien JA; Schlegel KS; Puri V; Uebele VN; Uslaner JM; Wang C; Converso A
    Bioorg Med Chem Lett; 2020 May; 30(9):127066. PubMed ID: 32173198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache.
    Blanco MJ; Benesh DR; Knobelsdorf JA; Khilevich A; Cortez GS; Mokube F; Aicher TD; Groendyke TM; Marmsater FP; Tang TP; Johnson KW; Clemens-Smith A; Muhlhauser MA; Swanson S; Catlow J; Emkey R; Johnson MP; Schkeryantz JM
    Bioorg Med Chem Lett; 2017 Jan; 27(2):323-328. PubMed ID: 27908761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR of substituted pyrazolo[1,5-a]quinazolines as dual mGlu(2)/mGlu(3) NAMs.
    Wenthur CJ; Morrison RD; Daniels JS; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2014 Jun; 24(12):2693-8. PubMed ID: 24794112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.